ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

110 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q3 2022.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,027,559 shares of 53,136,600 outstanding shares and own 67.8% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9,699,925 shares), FMR LLC (4,630,571 shares), Vivo Capital, LLC (4,220,048 shares), Logos Global Management LP (2,971,352 shares), ORBIMED ADVISORS LLC (2,871,000 shares), BlackRock Inc. (1,670,402 shares), VANGUARD GROUP INC (1,411,009 shares), EVENTIDE ASSET MANAGEMENT, LLC (902,000 shares), Redmile Group, LLC (752,097 shares), and Cormorant Asset Management, LP (712,079 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.